INCLISIRAN
inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe
INCLISIRAN (14101E)
14101E
Body System:
Manner of administration:Injection
Restriction (Streamlined authority code: 16295)
Indication: Familial heterozygous hypercholesterolaemia
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 16331)
Indication: Non-familial hypercholesterolaemia
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,849.80 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Leqvio | |||||
